Trials / Completed
CompletedNCT06093971
Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy
Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy: A Randomized Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- Male
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The investigators conduct a random assignment into either the remimazolam group or the propofol group. Depending on the group assignment, either remimazolam (0.2 mg/kg) or propofol (1.0 mg/kg) is administered. If necessary, additional doses of remimazolam (0.1 mg/kg) or propofol (0.5 mg/kg) are given. The standard anesthesia procedure of our institution is followed, and blood pressure data recorded during the surgery is analyzed (mean arterial pressure \<65mmHg is defined as hypotension).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | remimazolam | Remimazolam is administered for anesthesia induction. |
| DRUG | Propofol | Propofol is administered for anesthesia induction. |
Timeline
- Start date
- 2023-11-17
- Primary completion
- 2024-10-22
- Completion
- 2024-10-22
- First posted
- 2023-10-23
- Last updated
- 2024-12-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06093971. Inclusion in this directory is not an endorsement.